MPR rolls out revamped website

Share this article:
Monthly Prescribing Reference (MPR) has relaunched its website with a number of enhancements to functionality and design, as well as a new, easier-to-remember URL, www.eMPR.com.

The new site will continue to focus on drug information but now offers a beefed-up search capability that can filter information according to a number of different criteria, including relevance, therapeutic category and date.
Furthermore, accompanying each drug monograph is a series of related resource options, such as drug news, sponsored alerts, pharmacology notes, clinical charts, similar drugs and recent updates to the data. Also, users are now able to compare drugs, side by side.

The redesigned site is easier to navigate and now features links to related sites, such as www.myCME.com. It also offers a much wider range of options for sponsors.

Physicians have been using the print editions of MPR for more than 25 years, and Jim Pantaleo, MPR vice president and publisher, says the new site is part of an initiative to offer up-to-date, concise drug information to healthcare professionals during every part of their day and in the medium of their choice.

MPR is published by Prescribing Reference, Inc., part of Haymarket Media, which also publishes MM&M.
Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union